Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma
- Author(s)
- Dowling, MR; Cliff, ERS; Jeffrey, A; Cashion, C; Boyle, S; Li, J; Buss, T; MacDonald, R; Edelkina, A; Scott, Hw Md; O'Leary, N; Keir, MW; Belbachir, S; Westerman, DA; Tam, CS; Ho, PJ; Harrison, SJ; Barraclough, A; Inam, S; Blyth, E; Henden, AS; Vanguru, V; Dickinson, M;
- Journal Title
- Blood
- Publication Type
- Online publication before print
- Abstract
- In this retrospective analysis of 584 patients who received CAR T-cell therapy for LBCL at six Australian centres we found no association between time of infusion and outcome, accounting for confounders, suggesting minimal clinical impact of chronobiology in this setting.
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1182/blood.2025032307
- Open Access at Publisher's Site
https://doi.org/10.1182/blood.2025032307- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-03-05 03:10:34
Last Modified: 2026-03-05 03:10:47